Heat shock protein 90: translation from cancer to Alzheimer's disease treatment?
Open Access
- 3 December 2008
- journal article
- review article
- Published by Springer Nature in BMC Neuroscience
- Vol. 9 (S2) , S7
Abstract
Both malignant transformation and neurodegeneration, as it occurs in Alzheimer's disease, are complex and lengthy multistep processes characterized by abnormal expression, post-translational modification, and processing of certain proteins. To maintain and allow the accumulation of these dysregulated processes, and to facilitate the step-wise evolution of the disease phenotype, cells must co-opt a compensatory regulatory mechanism. In cancer, this role has been attributed to heat shock protein 90 (Hsp90), a molecular chaperone that maintains the functional conformation of multiple proteins involved in cell-specific oncogenic processes. In this sense, at the phenotypic level, Hsp90 appears to serve as a biochemical buffer for the numerous cancer-specific lesions that are characteristic of diverse tumors. The current review proposes a similar role for Hsp90 in neurodegeneration. It will present experimentally demonstrated, but also hypothetical, roles that suggest Hsp90 can act as a regulator of pathogenic changes that lead to the neurodegenerative phenotype in Alzheimer's disease.Keywords
This publication has 70 references indexed in Scilit:
- The complex p25/Cdk5 kinase in neurofibrillary degeneration and neuronal death: The missing link to cell cycleBiotechnology Journal, 2007
- Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathiesProceedings of the National Academy of Sciences, 2007
- Neuronal cell cycle re-entry mediates Alzheimer disease-type changesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2007
- Regulation of Alzheimer's disease amyloid-β formation by casein kinase IProceedings of the National Academy of Sciences, 2007
- The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteinsJournal of Clinical Investigation, 2007
- Opposing Roles of Transient and Prolonged Expression of p25 in Synaptic Plasticity and Hippocampus-Dependent MemoryNeuron, 2005
- NSAID and Antioxidant Prevention of Alzheimer's Disease: Lessons from In Vitro and Animal ModelsAnnals of the New York Academy of Sciences, 2004
- APP processing is regulated by cytoplasmic phosphorylationJournal of Cell Biology, 2003
- The Hallmarks of CancerCell, 2000
- Abnormal Alzheimer‐like phosphorylation of tau‐protein by cyclin‐dependent kinases cdk2 and cdk5FEBS Letters, 1993